Why the study?
The safety and efficacy of the new bidirectional rotational mechanical sheath TightRail for transvenous lead extraction required clinical assessment.
Does the bidirectional rotational mechanical sheath TightRail™ provide safe and efficacious transvenous lead extraction?
Does the bidirectional rotational mechanical sheath TightRail™ provide safe and efficacious transvenous lead extraction?
The TightRail bidirectional rotational mechanical sheath demonstrates a high safety and efficacy profile for transvenous lead extraction across a wide range of lead ages.
Answers are grounded in this paper and cite their sources.
TightRail may be feasible for TLE in small cohorts; hypothesis-generating and should not change practice without larger trials.
Aim The aim of this study is to assess the safety and efficacy of the new bidirectional rotational mechanical sheath TightRail™ (Spectranetics) for lead extraction. Methods and results This is a bicentric prospective study that included patients who underwent a transvenous lead extraction (TLE) in two Italian centers (San Raffaele Hospital and Humanitas Gavazzeni Hospital). From November 2016 to December 2018, 26 patients underwent a TLE procedure in which the TightRail™ was used. The new TightRail Sub‐C was used in 20 (76%) patients to overcome the fibrosis between the vessel and the first rib. Median age was 69 (IQR 60.7‐79.5) years. The indication for TLE were infection (57.7%) or lead dysfunction (42.3%). A total of 57 leads (range 1‐4), 40 of which using the TightRail (range 1‐4), were extracted. Overall mean implant duration was 98.2.0 ± 66.5 months. Mean age of the lead extracted with the TightRail sheath was 99.1 ± 70.2 months and was higher compared to that of the leads extracted manually (84.4 ± 60.3 months, P = .001). The overall clinical success was 100% and complete procedural success without the use of a snare was achieved in 98.3%. There were no cases of death or major complications and only two minor complications occurred. All patients were event‐free at 6‐month follow‐up. Conclusion This initial experience using the TightRail™ suggests a high safety and efficacy profile for extractions in a wide range of lead age.
No takes yet. Share an insight, caveat, or question.
Mazzone et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: